Covid-19 and Parkinson's disease: Nursing care, vaccination and impact on advanced therapies

Int Rev Neurobiol. 2022:165:173-196. doi: 10.1016/bs.irn.2022.04.005. Epub 2022 Jul 9.

Abstract

The Coronavirus Disease 2019 (Covid-19) pandemic has created many challenges for the Parkinson's Disease (PD) care service delivery, which has been established over the past decades. The need for rapid adjustments to the new conditions has highlighted the role of technology, which can act as an enabler both in patient-facing aspects of care, such as clinical consultations, as well as in professional development and training. The Parkinson's Disease Nurse Specialists (PNSs) play a vital role in the effective management of people with PD (PwP). Maintaining optimum functionality and availability of device aided therapies is essential in order to ensure patients' quality of life. PwP are particularly recommended to use vaccination as a basic protection from the virus. The long-term consequences of this pandemic on PwP are highly uncertain, and education, support and reassurance of patients and their families may help ease their burden.

Keywords: Advanced therapies; Covid-19; Parkinson's Nurse Specialist; Parkinson's disease; Vaccination.

MeSH terms

  • COVID-19* / prevention & control
  • Humans
  • Parkinson Disease* / drug therapy
  • Quality of Life
  • Vaccination